Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial

GlobeNewswire · 财报与经营业绩 · October 29, 2026 at 7:00 AM ET

Read the full report at the original publisher.